BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
69.71
-4.81 (-6.45%)
At close: Apr 28, 2026, 4:00 PM EDT
69.98
+0.27 (0.39%)
After-hours: Apr 28, 2026, 7:25 PM EDT
BridgeBio Pharma Market Cap
BridgeBio Pharma has a market cap or net worth of $13.51 billion as of April 28, 2026. Its market cap has increased by 109.55% in one year.
Market Cap
13.51B
Enterprise Value
14.79B
1-Year Change
109.55%
Ranking
Category
Stock Price
$69.71
Market Cap Chart
Since June 27, 2019, BridgeBio Pharma's market cap has increased from $3.32B to $13.51B, an increase of 307.08%. That is a compound annual growth rate of 22.78%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Moderna | 18.70B |
| Summit Therapeutics | 16.50B |
| Genmab | 16.26B |
| Ascendis Pharma | 13.72B |
| Jazz Pharmaceuticals | 12.56B |
| Ionis Pharmaceuticals | 11.86B |
| Madrigal Pharmaceuticals | 11.85B |
| Exelixis | 11.41B |